+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

genOway SA (ALGEN) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 35 Pages
  • November 2021
  • GlobalData
  • ID: 1292308
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

genOway SA (ALGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


genOway SA (genOway) is a provider of customized genetically-modified (GM) mouse, rat and as well as cellular models for experiments, research, drug development for various therapeutic areas such as cancer, cardiovascular diseases, metabolic Diseases, immunological and neurological disorders. The company applies various technologies such as homologous recombination, Internal Ribosome Entry Site (IRES), Cre-ERt2, CRISPR/Cas9 Gene Editing, Recombinase-Mediated Cassette Exchange (RMCE), Tet-On/Off and FLEx to generate its various types of physiologically relevant models. The company provides its services to pharmaceutical/life sciences companies and research institutes and has generated over 2000 genetically-modified (GM) models. genOway is headquartered in Lyon, France.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • genOway SA - Key Facts
  • genOway SA - Key Employees
  • genOway SA - Key Employee Biographies
  • genOway SA - Major Products and Services
  • genOway SA - History
  • genOway SA - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries

Section 2 - Company Analysis
  • Company Overview
  • genOway SA - Business Description
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: France
  • Performance
  • Geographical Segment: North America
  • Performance
  • Geographical Segment: Other Countries
  • Performance
  • genOway SA - SWOT Analysis
  • SWOT Analysis - Overview
  • genOway SA - Strengths
  • genOway SA - Weaknesses
  • genOway SA - Opportunities
  • genOway SA - Threats
  • genOway SA - Key Competitors

Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • genOway SA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • genOway SA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • genOway SA, Recent Deals Summary

Section 5 - Appendix
  • Methodology
  • Ratio Definitions
  • About The Publisher
  • Contact The Publisher
  • Disclaimer

List of Tables
  • genOway SA, Key Facts
  • genOway SA, Key Employees
  • genOway SA, Key Employee Biographies
  • genOway SA, Major Products and Services
  • genOway SA, History
  • genOway SA, Subsidiaries
  • genOway SA, Key Competitors
  • genOway SA, Ratios based on current share price
  • genOway SA, Annual Ratios
  • genOway SA, Interim Ratios
  • genOway SA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • genOway SA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • genOway SA, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios

List of Figures
  • genOway SA, Performance Chart (2016 - 2020)
  • genOway SA, Ratio Charts
  • genOway SA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • genOway SA, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021



Companies Mentioned

A selection of companies mentioned in this report includes:

  • Elsalys Biotech SA
  • Transposagen Biopharmaceuticals Inc
  • Taconic Biosciences Inc
  • Janvier Labs SAS
  • Sigma Life Science
  • Caliper Life Sciences Inc